Jon Hammack

Jon Hammack is a Partner and serves as Head of Healthcare, focused on medical technology and devices. He joined the firm in 2021.

Jon has 20 years of healthcare investment banking experience and specializes in advising clients in the medical technology and outsourced services sectors. He has advised boards of directors and special committees as well as companies on a broad range of transactions, including mergers, acquisitions, divestitures, leveraged buyouts, restructurings and capital raising solutions.

Prior to joining Solomon Partners, Jon was a Managing Director at Moelis & Company where he spent eight years leading and expanding the firm’s medical technology sector. Before Moelis, Jon was a Managing Director and Head of Medical Technology at Morgan Stanley.

Over the past two decades, Jon has advised on numerous key healthcare transactions with total transaction value over $100 billion. Select transactions include:

• Acquisition of ASP Global by Platinum Equity
• Sale of TIDI Products to TJC
• Acquisition of CoreLink by Zavation
• Growth Investment in Nox Health by Vestar Capital
• Acquisition of Magellan Rx by Prime Therapeutics
• Sale of Zavation Medical to Gemspring
• Sale of Northfield Medical to Agiliti
• Sale of Clinical Innovations to LABORIE Medical
• Sale of Hu-Friedy to Cantel Medical
• Sale of Invuity to Stryker
• Sale of Zest Dental to BC Partners
• Sale of Argon Medical to Weigao
• Acquisition of MIS Implants by Dentsply Sirona
• Merger of Dentsply and Sirona